- Home
- Health
- News
- Spain's Drug Agency Says to Continue Using Hydroxychloroquine Despite Study on Death Risks
Spain's Drug Agency Says To Continue Using Hydroxychloroquine Despite Study On Death Risks
Faizan Hashmi Published May 28, 2020 | 05:45 PM
The Spanish Agency of Medicines and Medical Devices (AEMPS) has doubted the reliability of a study published in The Lancet medical journal that suggested a link between the use of hydroxychloroquine and increased death risks among coronavirus patients, saying that it will continue clinical trials and experimental use of the malaria drug
MOSCOW (UrduPoint News / Sputnik - 28th May, 2020) The Spanish Agency of Medicines and Medical Devices (AEMPS) has doubted the reliability of a study published in The Lancet medical journal that suggested a link between the use of hydroxychloroquine and increased death risks among coronavirus patients, saying that it will continue clinical trials and experimental use of the malaria drug.
Last week's study in The Lancet suggested that coronavirus patients who received hydroxychloroquine were dying at higher rates than other individuals with the disease. In the wake of this, the World Health Organization announced on Monday that it was temporarily halting its clinical trials on the drug. France, too, has suspended its use.
In a statement, quoted by El Pais, an AEMPS official said that the study "presents useful information."
"But it is an observational study, not a clinical trial, so it does not allow us to get convincing and indisputable evidence because there are many factors that affect these studies and can lead to them being not completely reliable," the official stated.
According to the official, AEMPS has not received any safety alerts regarding the drug.
"So ... we do not believe that there is a reason to suspend ongoing trials or halt the use of the drug as part of an experimental treatment," the agency said.
According to AEMPS, 15 clinical trials of hydroxychloroquine are currently underway in Spain. In addition, almost all hospitals across the country are conducting observational studies.
In addition, at least 85 percent of hospitalized coronavirus patients nationwide are receiving the drug, El Pais said.
As of Wednesday, Spain has confirmed 236,769 COVID-19 cases, including 27,118 deaths.
Recent Stories
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 29 March 2024
Today Gold Rate in Pakistan 29 March 2024
Journalists call for global action to end Gaza’s humanitarian crisis
CM for generating opportunities to bring direct int'l investment
Pakistan retains position in FTSE secondary emerging market
High Commissioner of Malaysia hosts Iftar dinner reception
NEPRA announces 2nd quarterly adjustment in power bills with Rs 1.68 cut per uni ..
Hoopo Inc. Collaborates with SAU to Install Solar-Powered RO Plant
04 killed in Spain as Storm Nelson looms
Russian military jet crashes into sea off Crimea: Governor
Rain-windstorm/thunderstorm likely at various parts of country
Implementation of Sindh Agriculture Workers Act-2019 demanded
More Stories From Health
-
Increased diagnostic testing for drug resistance
6 days ago -
IRD releases groundbreaking results of end TB programme
8 days ago -
Increased diagnostic testing for drug resistance TB will enhance patients’ treatment outcome
11 days ago -
JRF to provide insulin to underprivileged diabetic patients
13 days ago -
MBBS third professional annual exams 2023: check results here
14 days ago -
CM Maryam visits PIC, inquiries after patients
16 days ago
-
Health expert recommends exercise for weight loss in Ramazan
18 days ago -
Blood camp held at SNGPL office
18 days ago -
Free Medical camp for people with mental, physical disabilities
24 days ago -
Breast cancer has become most common disease in few years: expert
24 days ago -
Punjab Healthcare Commission shuts down 634 illegal treatment centers
24 days ago -
COMSTECH, Al-Shifa Trust team conduct free cataract eye surgeries in Somalia
24 days ago